FDA Continues to Monitor Safety of Current COVID-19 Vaccines Available to the Public

FDA Continues to Monitor Safety of Current COVID-19 Vaccines Available to the Public

The FDA ensures it is doing its best to make sure each vaccine is completely safe to get.

The public trusts the FDA that all medical products, including the COVID-19 vaccines, are safe and effective. As a part of the standard process for inspecting all manufacturing facilities, the FDA recently completed an inspection of Emergent Biosolutions. This is a proposed manufacturing facility for the Johnson & Johnson vaccine.

Johnson & Johnson announced its facility is not authorized to distribute the vaccine in the U.S. The FDA investigations that are conducted are thorough and carefully thought out. These assessments include going through records, manufacturing procedures, staff training, facility operation and product quality. According to an article, during the inspection of Emergent Biosolutions that ended Tuesday, the FDA cited a number of requirements and standards that were not met.

The FDA is intended to identify these conditions then help identify a path to move forward to fix the issues and be safe. Emergent Biosolutions agreed to pause new productions while it undergoes additional testing and will be thoroughly evaluated before potentially distributing again.

These actions, however, are unrelated to an ongoing evaluation by the FDA and CDC of a specific blood clot reported in a very small number of people after receiving the Johnson & Johnson vaccine.

The FDA wants to ensure the COVID-19 vaccines that are distributed to everyone in the country have met the highest standards for quality, safety and effectiveness.

About the Author

Shereen Hashem is the Associate Content Editor for Occupational Health & Safety magazine.

Product Showcase

  • Matrix's OmniPro Vision AI Collision Avoidance System

    OmniPro Vision AI is a state-of-the-art collision avoidance system that features NIOSH award-winning Visual Artificial Intelligence (AI) technology. This highly accurate, powerful system identifies and alerts on pedestrians, vehicles and specified objects, ensuring safer facilities, mining operations and industrial sites. With its web-based cloud application, OmniPro Vision AI also logs and analyzes a wide range of data related to zone breach notifications. Operating without needing personal wearable devices or tags, OmniPro has visual and audible zone breach alerts for both operators and pedestrians. Read More

  • SwabTek® Cannabis Test Kit

    The SwabTek® Cannabis Test Kit is a single-use spot test designed for use in screening for cannabis compounds in any sample type or on any surface. The test is capable of identifying the presumed presence of cannabinoids in very small quantities, with a level of detection as little as 6 μg in mass. Learn more about the SwabTek® Cannabis Test Kit and the rest of SwabTek surface drug testing solutions through the webinar titled "Everything You Want To Know About Surface Testing" Read More

  • Glove Guard® Clip

    Safety should never be compromised, especially when it comes to proper glove usage. The Glove Guard® clip enhances safety by encouraging employees to keep their gloves with them at all times. This reduces the risk of accidents and injuries on the job. By ensuring everyone has their gloves readily available, we help promote a culture of safety and efficiency. The Glove Guard® clip is designed to withstand the toughest work environments. Constructed from robust materials made in the USA, it can endure extreme conditions, including harsh weather, and rigorous activities. Read More

Featured

Artificial Intelligence

Webinars